The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lalonde James since 2014.
The trader's CIK number is 1599677.
At the time of the last reporting, Lalonde James was the SVP, R&D of Codexis, Inc.. (stock ticker symbol CDXS).
Also see all insider trading activities at Codexis, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | CDXS | 0 | $0 | 19,999 | $373,022 | 19,999 | $149,191 |
| 2018 | CDXS | 0 | $0 | 78,749 | $1,220,256 | 0 | $0 |
| 2017 | CDXS | 0 | $0 | 0 | $0 | 6,666 | $16,331 |
| 2015 | CDXS | 0 | $0 | 9,441 | $33,235 | 26,666 | $27,998 |
| 2014 | CDXS | 0 | $0 | 0 | $0 | 27,350 | $18,598 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-13 | CDXS | Option Ex | 17,621 | 7.46 | 131,452 |
| 2019-05-14 | CDXS | Option Ex | 2,378 | 7.46 | 17,739 |
| 2019-05-13 | CDXS | Sale | 17,621 | 18.61 | 327,962 |
| 2019-05-14 | CDXS | Sale | 2,378 | 18.95 | 45,060 |
| 2018-11-12 | CDXS | Sale | 6,727 | 15.57 | 104,719 |
| 2018-11-13 | CDXS | Sale | 6,726 | 15.22 | 102,396 |
| 2018-09-04 | CDXS | Sale | 17,915 | 17.16 | 307,349 |
| 2018-09-05 | CDXS | Sale | 12,381 | 17.35 | 214,847 |
| 2018-07-16 | CDXS | Sale | 7,500 | 15.53 | 116,460 |
| 2018-07-17 | CDXS | Sale | 7,500 | 15.27 | 114,555 |
| 2018-05-15 | CDXS | Sale | 10,000 | 12.90 | 129,030 |
| 2018-05-14 | CDXS | Sale | 10,000 | 13.09 | 130,900 |
| 2017-01-05 | CDXS | Option Ex | 6,666 | 2.45 | 16,331 |
| 2015-11-10 | CDXS | Option Ex | 10,275 | 1.05 | 10,788 |
| 2015-11-11 | CDXS | Option Ex | 16,391 | 1.05 | 17,210 |
| 2015-11-10 | CDXS | Sale | 3,636 | 3.52 | 12,802 |
| 2015-11-11 | CDXS | Sale | 5,805 | 3.52 | 20,433 |
| 2014-07-01 | CDXS | Option Ex | 27,350 | .68 | 18,598 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lalonde James (SVP, R&D of Codexis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.